Protective Effects of Enteral Nutrition Supplemented with Crassostrea hongkongensis Polysaccharides Against 5-Fluorouracil-Induced Intestinal Mucosal Damage in Rats. 2018

Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
1 Key Laboratory of Tropical Marine Bio-Resources and Ecology/Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology , Chinese Academy of Sciences, Guangzhou, China .

Chemotherapeutics, including 5-fluorouracil (5-FU), often damage the intestinal mucosal barrier and cause intestinal mucositis (IM). Supplementation with immunoregulatory polysaccharides from Crassostrea hongkongensis has been shown to positively influence the effectiveness and toxicity of 5-FU. Therefore, we studied the effects of oyster polysaccharides on 5-FU-induced intestinal mucosal damage in rats. The C30-60% ethanol-precipitated fraction of polysaccharides promoted IEC-6 cell proliferation and exhibited a maximal effect at a 0.0195 mg/mL concentration. Moreover, treatment with C30-60% polysaccharide-based nutrition formula (OPNF) partially prevented the 5-FU-induced degenerative changes in the histology and ultrastructure of small intestinal mucosa. In addition, the endotoxin level of rats fed with 5-FU and OPNF decreased to the normal control level. Furthermore, the 5-FU-induced increase of proinflammatory cytokine interleukin (IL)-2 and the decrease of anti-inflammatory cytokine IL-10 level in the peripheral blood were significantly attenuated by OPNF administration. In conclusion, Oyster C30-60% polysaccharides can ameliorate 5-FU-induced IM by partially preventing mucosal damage, reducing inflammation, and promoting immunity.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D004750 Enteral Nutrition Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes. Enteral Feeding,Force Feeding,Nutrition, Enteral,Tube Feeding,Gastric Feeding Tubes,Feeding Tube, Gastric,Feeding Tubes, Gastric,Feeding, Enteral,Feeding, Force,Feeding, Tube,Feedings, Force,Force Feedings,Gastric Feeding Tube,Tube, Gastric Feeding,Tubes, Gastric Feeding
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D049896 Crassostrea A genus of oysters in the family OSTREIDAE, class BIVALVIA. Oysters, Eastern,Crassostrea gigas,Crassostrea virginica,Oyster, Eastern,Crassostrea giga,Crassostrea virginicas,Crassostreas,Eastern Oyster,Eastern Oysters,gigas, Crassostrea,virginica, Crassostrea
D052016 Mucositis An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY). Mucositides

Related Publications

Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
April 2016, Zhen ci yan jiu = Acupuncture research,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
February 2009, Nutrition (Burbank, Los Angeles County, Calif.),
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
December 2010, Burns : journal of the International Society for Burn Injuries,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
February 2010, Clinical nutrition (Edinburgh, Scotland),
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
June 2013, European review for medical and pharmacological sciences,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
October 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
August 2010, The journal of medical investigation : JMI,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
October 2009, Clinical nutrition (Edinburgh, Scotland),
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
September 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Bingna Cai, and Peng Wan, and Huili Sun, and Deke Chen, and Hua Chen, and Xin Chen, and Jianyu Pan
April 2018, Iranian journal of basic medical sciences,
Copied contents to your clipboard!